Clinical Trials Browser

INDUSTRY × Carcinoma, Squamous Cell × VTX-2337 × Clear all

NCT03906526 2023-02-24

A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer

Phase 1 Terminated

Carcinoma, Squamous Cell, Head and Neck Neoplasms